Pharmaceutical Technology-01-02-2020

As mergers continue and operations become more complex, simplifying procedures and training can prevent costly morale, quality, and compliance problems.

As the high cost of drugs continues to erode public opinion, experts ask whether price controls are the best, or only, way to improve access to medicines and regain the public’s trust.

Pressures on FDA will affect industry’s success in bringing new therapies to market.

The promise of new therapies is tempered by the need for affordability, safety, and ethics.

The NXT Series from ACG Group consists of the Protab 300 NXT, Protab 700 NXT, BMax NXT (pictured), KartonX NXT, and Verishield CS18 NXT machines for production, packaging, and inspection.

ReNu SU (single-use) Technology cartridge assemblies from Watson-Marlow Fluid Technology Group are designed for the development and production of personalized medicines.

The Ross VCB-0.25 Tumble Blender is suited for specialty blends with extremely minor active components and additives.

Terracon Corporation unveiled a line of turnkey, magnetic-drive plastic mixing systems for applications within pharmaceutical markets.

FDA’s approval rate slowed, but the US agency is still ahead of its international counterparts in green-lighting new drugs for market.

With a positive employment market, some bio/pharma professionals explore options for career advancement.

Data collected through the Industrial Internet of Things enable predictive maintenance.

Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.

Focusing on symptoms instead of root causes locks teams into a corrective, rather than preventive, mindset.

Biologics raise unique formulation and development challenges, and industry is still on a learning curve to get the best out of these diverse and complex therapies.

Pharmaceutical companies work toward a circular economy by using sustainable packaging.

Past mistakes and misstatements have adversely influenced industry decontamination practices with vapor phase hydrogen peroxide, and this article endeavors to clarify the process.

The aim of this study was to prepare taste-masked drug-resin complex using ion exchange resin Kyron T-134.

In 2020, European regulators are expected to start to be even more active in encouraging drugs innovations rather than hindering them through legal restrictions.

As a new decade has begun, this editorial reviews some of the biggest, brightest, and boldest happenings from the industry over the past 10 years.

Regulatory mandates, niche diseases, and patient-centric solutions have all impacted pharma packaging over the years and are expected to help shape the future of the sector.

Click the title above to open the Pharmaceutical Technology January 2020 issue in an interactive PDF format.

PTE looks ahead to 2020’s edition of Pharmapack-the pharma industry’s dedicated packaging and drug delivery event.

Without careful consideration and understanding, new regulations for medical devices could lead to the withdrawal of combination products from the market.